Basic info
Industry
biotechnology research
Sectors
biotherapeutics
Biotechnology
Gene editing
Leukemia
chimeric antigen receptor
Myeloma
SHP-1
T cells
CART immunotherapy
Test and Measurement
Bioinformatics
DIAGNOSIS
CRISPR
CD30
Hematology
Physician
Patient
Lymphoma
CD2
CD5
Cell engineering
CRISPR-Cas9
CD7
Cancer
Date founded
2021
Funding rounds raised
Total raised
$10M
from 3 investors over 3 rounds
v
viTToria biotherapeutics raised $10M on June 7, 2022
Investors: Tellus BioVentures, SV Life Sciences and Agent Capital